Dark

CGEM
Cullinan Therapeutics, Inc. Common Stock
stock NASDAQ

At Close

Sep 23, 2026 3:59:58 PM EDT

16.86USD-22.197%(-4.81)2,593,736

14.40Bid 19.45Ask 5.05Spread

Pre-market

Sep 23, 2026 8:02:30 AM EDT

21.60USD-0.323%(-0.07)1,880

After-hours

Sep 23, 2026 4:57:30 PM EDT

17.36USD+2.974%(+0.50)7,525

OverviewOptionsHistoricalExchangesShortsMore

open chart

Market Cap

1.09B

Headquarters

Cambridge, MA, USA

Industry

Biotechnology

Next Earnings

Nov 5, 2026 (43d)

CGEM Stats

Avg. Vol. 10 Day

1,208,364

Avg. Vol. 30 Day

891,843

Employees

Market Cap

1,086,307,235

Shares Out.

64,354,694

On/Off Exchange

66%/34%

6 Month Beta

1.10

1 Year Beta

1.32

2 Year Beta

1.04

3 Year Beta

1.21

52 Week Low

5.68

52 Week High

23.19

SMA50

19.78

SMA200

15.21

1 Week

-18.18%

1 Month

-22.64%

3 Month

-4.90%

6 Month

+31.46%

1 Year

+177.18%

2 Year

+1.50%

5 Year

-28.69%

Profile

cullinan oncology is focused on investing in and developing a highly diversified portfolio of oncology therapeutics with a unique, cost-efficient business model. sourced from the cullinan dry lab as well as external collaborators, cullinan's assets are managed by a single, highly experienced team of oncology professionals and drug developers across a lean, capital efficient operating model.

CGEM Stock Summary

Cullinan Therapeutics, Inc. Common Stock (NASDAQ:CGEM) stock price today is $16.86, and today's volume is 2,593,736. CGEM is down -22.197% today. The 30 day average volume is 891,843. CGEM market cap is 1.09B with 64,354,694 shares outstanding.

.dark-mode .qPCFl8{ color: white; background-color: #333333; border: 2px solid white; }.light-mode .qPCFl8{ color: #333333; background-color: white; border: 2px solid #333333; }CGEMCullinan Therapeutics, Inc. Common Stockstock NASDAQ

CGEM Stock Summary

CGEM
Cullinan Therapeutics, Inc. Common Stock
stock NASDAQ